This product is a recombinant human antibody scFv fragment that recognizes mutant p53. F2 was capable of binding the common epitope of the mutant p53. TARl is capable of inducing cell death by apoptosis in cancerous cell lines expressing endogenous mutant p53 proteins.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0273CQ | Human Anti-mutant p53 Recombinant Antibody (clone F2 scFv (TARl)) | ELISA, FC, Apop, FuncS | Human IgG |
HPAB-0274CQ | Human Anti-mutant p53 Recombinant Antibody (clone E6) | ELISA, FC, WB | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0273CQ-F(E) | Human Anti-mutant p53 Recombinant Antibody (clone F2 scFv (TARl)); Fab Fragment | ELISA, FC, Apop | Human Fab |
HPAB-0274CQ-F(E) | Human Anti-mutant p53 Recombinant Antibody (clone E6); Fab Fragment | ELISA, FC | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0274CQ-S(P) | Human Anti-mutant p53 Recombinant Antibody (clone E6); scFv Fragment | ELISA, FC | Human scFv |
There are currently no Customer reviews or questions for HPAB-0273CQ-S(P). Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.